Cemiplimab 350 MG Intravenous Solution
OU-SCC-LAG-BOOST
Phase 2 small_molecule active
Quick answer
Cemiplimab 350 MG Intravenous Solution for Clear Cell Renal Cell Carcinoma is a Phase 2 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- REGENERON PHARMACEUTICALS, INC.
- Indication
- Clear Cell Renal Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active